System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ralph Mösges is an expert in Immunology at University Hospital Cologne (Germany). As of October 2026, ScienceLeadR ranks Ralph Mösges in the top 1% of experts worldwide for Rhinitis, Nose Diseases and Hypersensitivity. Ralph Mösges has authored 440 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 1 of them ongoing. SLR score: 1,349 (community average: 125). How the SLR is computed.

LeadR Profile

Ralph Mösges University Hospital Cologne Germany
1 349 ScienceLeadR Reputation 1349

Unlock

Register Login
Network Map

Immunology

Subspecialties: Allergy - Pulmonology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026
Source: PubMed

University of Cologne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 440

Citations

Citations: 12 370 1st author: 74 Last author: 137 Unique author: 23

Main journals

Allergy 68
Clin Transl Allergy 39
J Allergy Clin Immunol 23
HNO 19
ALLERGOLOGIE 17

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Short-Course Subcutaneous Immunotherapy With Mannan-Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements.
PMID 42830415 — quality of life, safety, allergoids, immunoglobulins, immunotherapy, mannans, therapeutics		Clin Transl Allergy20260
Trends and Patterns for the Use of Herbal Medicinal Products for Gynaecological Ailments.
PMID 41937616 — safety, pharmaceutical preparations, aged, therapeutics		Phytother Res20262
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.
PMID 42057631 — hypersensitivity, allergoids, rhinitis, allergic, seasonal, allergens, immunotherapy, therapeutics, allergy		Clin Exp Allergy20261
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.
PMID 42011838 — hypersensitivity, drug-related side effects and adverse reactions, rhinitis, asthma, steroids		Allergy20260
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.
PMID 41375868 — allergoids, immunotherapy, mannans, therapeutics		J Clin Med20252

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1

By phase:

N/A 11
Phase 3 1
Phase 4 1

By status:

Completed 12
Recruiting 1

By type:

Observational 10
Interventional 3

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 2
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
GRASS (Grass MATA MPL Real world Assessment Study)
NCT07412990 — hypersensitivity, rhinitis, allergic, seasonal, allergy		N/ARecruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS